VRTX · News · 20260915N

JOURNAVX Demand and Access

VERTEX PHARMACEUTICALS INC / MA · 2026-09-15 · Importance 29 · Surprise 30

Vertex partnered with Olympic skier Lindsey Vonn to promote JOURNAVX, its non-opioid pain treatment. Vonn is advocating for the drug after suffering a severe leg injury at the 2026 Winter Games and experiencing negative side effects from opioids. The campaign is intended to increase awareness and sales of JOURNAVX, which has recently reported revenue growth despite an initially weaker launch.

Key facts

• Olympic skier Lindsey Vonn has partnered with Vertex Pharmaceuticals to promote its non-opioid pain drug, Journavx. source
• The collaboration between Lindsey Vonn and Vertex aims to boost awareness and sales for Journavx. source
• Journavx has seen recent revenue growth despite initial underperformance. source
• Lindsey Vonn suffered a severe leg injury at the 2026 Winter Games. source